Abstract:
The invention is directed to bodies comprising an amorphous carbon particle on which are supported nanoparticles of an oxide of lanthanide. These bodies find use as a pharmaceutical for use in a surgery or therapy and diagnostic methods. The bodies can be made by a process comprising impregnating a carbon source material by contacting it with a solution of a salt of said lanthanide; drying said impregnated carbon source material; and subjecting said dried impregnated material to pyrolysis under inert conditions.
Abstract:
The invention is in the field of modified carbon products. More in particular, the invention is in the field of graphitized activated carbon bodies. The invention is directed to carbon bodies and ferromagnetic carbon bodies, the production of these bodies from activated carbon, and the applications of the carbon bodies and ferromagnetic carbon bodies, for instance in water treatment and in electrochemical applications.
Abstract:
The invention relates to nano-particles comprising metallic ferromagnetic nanocrystals combined with either amorphous or graphitic carbon in which or on which chemical groups are present that can dissociate in aqueous solutions. According to the invention there is provided nano-particles comprising metal particles of at least one ferromagnetic metal, which metal particles are at least in part encapsulated by graphitic carbon. The nano-particles of the invention are prepared by impregnating carbon containing bodies with an aqueous solution of at least one ferromagnetic metal precursor, drying the impregnated bodies, followed by heating the impregnated bodies in an inert and substantially oxygen-free atmosphere, thereby reducing the metal compounds to the corresponding metal or metal alloy.